The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage
The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage
复制标题
DOI:
10.1074/mcp.m300089-mcp200
复制
发表时间:
2004-06-01
影响因子:
7
通讯作者:
Hupp, TR
中科院分区:
文献类型:
--
作者:
Pohler, E;Craig, AL;Hupp, TR
The esophageal epithelium is subject to damage from bile acid reflux that promotes normal tissue injury resulting in the development of Barrett's epithelium. There is a selection pressure for mutating p53 in this preneoplastic epithelium, thus identifying a physiologically relevant model for discovering novel regulators of the p53 pathway. Proteomic technologies were used to identify such p53 regulatory factors by identifying proteins that were overexpressed in Barrett's epithelium. A very abundant polypeptide selectively expressed in Barrett's epithelium was identified as anterior gradient- 2. Immunochemical methods confirmed that anterior gradient- 2 is universally up- regulated in Barrett's epithelium, relative to normal squamous tissue derived from the same patient. Transfection of the anterior gradient- 2 gene into cells enhances colony formation, similar to mutant oncogenic p53 encoded by the HIS175 allele, suggesting that anterior gradient- 2 can function as a survival factor. Deletion of the C- terminal 10 amino acids of anterior gradient2 neutralizes the colony enhancing activity of the gene, suggesting a key role for this domain in enhancing cell survival. Constitutive overexpression of anterior gradient- 2 does not alter cell- cycle parameters in unstressed cells, suggesting that this gene is not directly modifying the cell cycle. However, cells overexpressing anterior gradient- 2 attenuate p53 phosphorylation at both Ser15 and Ser392 and silence p53 transactivation function in ultraviolet ( UV)- damaged cells. Deletion of the C- terminal 10 amino acids of anterior gradient- 2 permits phosphorylation at Ser15 in UVdamaged cells, suggesting that the C- terminal motif promoting colony survival also contributes to suppression of the Ser15 kinase pathway. These data identify anterior gradient2 as a novel survival factor whose study may shed light on cellular pathways that attenuate the tumor suppressor p53. M